N EW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection ...

Panelists discuss how payers typically require step therapy with SGLT2 inhibitors before approving nonsteroidal MRAs due to ...

Adults with heart failure with reduced ejection fraction (HFrEF) who took a "polypill" combining medications prescribed for the treatment of heart failure, had improved heart function and symptoms, ...

Prioritizing education and shared decision-making can help patients with newly diagnosed heart failure feel less overwhelmed, ...

EDEN PRAIRIE, Minn., Oct. 07, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced ...

Approximately 6.7 million Americans over the age of 20 currently live with heart failure, with this number projected to rise to 8.5 million by 2030. The lifetime risk of developing heart failure has ...

LYNCHBURG, Va. (WSET) — Putting one foot in front of the other used to be exhausting for Angie Woody. "I was having trouble breathing," Woody said. "Simple tasks would wind me." About a year ago ...

"Congestive Heart Failure Market Insight, Epidemiology and Market Forecast"DelveInsight Business Research's analysis underscores the transformative implications of the FDA's approval of ENBUMYST ...

People who take the insomnia treatment melatonin long-term have double the risk of heart failure, according to a recent study ...

A multi-institution research team led by Georgetown University Medical Center has developed and validated a model estimating ...

New York, March 31, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Congestive Heart Failure Treatment Device Market - Premium Insight, Competitive News Feed ...